NeuPath Health price target cut by Stifel to C$0.58
Stifel cut its price target for NeuPath Health Inc. to C$0.58 from C$0.68 while maintaining a Strong Buy rating, per Baystreet.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.